República Checa - checo - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 14884 trihydrÁt vÁpenatÉ soli atorvastatinu; 16227 ezetimib - tableta - 10mg/40mg - atorvastatin a ezetimib

República Checa - checo - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 14884 trihydrÁt vÁpenatÉ soli atorvastatinu; 16227 ezetimib - tableta - 10mg/80mg - atorvastatin a ezetimib

Unión Europea - checo - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 a 5.

Unión Europea - checo - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomid - roztroušená skleróza - selektivní imunosupresiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Unión Europea - checo - EMA (European Medicines Agency)

theravia - dexamethason - mnohočetný myelom - kortikosteroidy pro systémové použití - léčba mnohočetného myelomu.

Unión Europea - checo - EMA (European Medicines Agency)

nordic group b.v. - metotrexát - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastická činidla - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Unión Europea - checo - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Unión Europea - checo - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva, selektivní imunosupresiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

República Checa - checo - SUKL (Státní ústav pro kontrolu léčiv)

adamed pharma s.a., czosnów polsko - 16227 ezetimib - tableta - 10mg - ezetimib

República Checa - checo - SUKL (Státní ústav pro kontrolu léčiv)

mylan ireland limited, dublin array - 8500 akarbosa - tableta - 100mg - akarbosa